New Delhi, April 15 (IANS) Healthcare companies in India are expected to deliver high single-digit revenue growth (year-on-year) in the fourth quarter of FY26 (Q4 FY26), a report showed on Wednesday.However, EBITDA margins will materially be corrected, according to the report by Systematix.“Median growth is estimated at 12 per cent for revenue and 3.6 per cent for EBTIDA, with net earnings likely witnessing a 14 per cent decline, the report mentioned.The primary driver of this on-year decline …
Latest Sun Pharma News & Updates
Mumbai, April 10 (IANS) Indian equity benchmarks traded sharply higher on Friday, mirroring gains in global markets despite fresh geopolitical tensions and concerns over the closure of the Strait of Hormuz.Sensex climbed as much as 0.82 per cent or 630 points to hit an intra-day high of 77261 in early trade, while Nifty surged 0.85 per cent or 203 points to trade at 23,978.Earlier, the 30-share Sensex opened at 77,121, up 0.64 per cent or 489 points, while the 50-share index began the session at…
Mumbai, April 3 (IANS) Indian equity markets closed lower for the sixth consecutive week amid escalating geopolitical tensions in West Asia and sharp currency fluctuations, with both headline indices ending in the red during a shortened four-day trading week.Sensex ended at 73,319.55 on Thursday, down 263.67 points or 0.35 per cent, compared to the previous Friday’s close. Nifty 50 settled at 22,713.10, a decline of 106.50 points or 0.46 per cent on a week-on-week basis.In the final session of t…
Mumbai, April 2 (IANS) Indian stock markets opened sharply lower on Thursday, with key equity benchmarks declining more than 1 per cent amid fresh escalation in the West Asia conflict.Sensex opened at 72,262, down 872 points or 1.19 per cent, while the Nifty fell 1.31 per cent or around 300 points to open at 22,383.40. Both the indices fell further as trading progressed in early hours.All sectors opened in the red, with banking, realty, chemicals, auto, metal, and healthcare among the top losers…
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Mumbai, March 2 (IANS) Indian stock markets closed sharply lower on Monday as rising tensions between the US and Iran dampened investor sentiment and triggered selling across sectors.The benchmark Nifty fell 1.24 per cent, or 312.95 points, to settle at 24,865.70. The Sensex dropped 1.29 per cent, or 1,048.34 points, to close at 80,238.85, marking its lowest level since September 2025.Although the indices recovered some losses from the day’s lows, they remained firmly in the red by the end of …
Mumbai, Feb 26 (IANS) The Indian stock market ended a volatile trading session on a mixed note on Thursday, with healthcare and PSU bank stocks leading the gains while media and FMCG shares lagged behind.The benchmark Nifty closed marginally higher by 0.06 per cent, or 14.05 points, at 25,496.55. In contrast, the Sensex slipped 27.46 points, or 0.03 per cent, to settle at 82,248.61.Commenting on Nifty technical outlook, experts said that a decisive close above 25,700 accompanied by strong volume…
Mumbai, Feb 25 (IANS) Indian stock markets ended slightly higher on Wednesday, even though they gave up most of their early gains during the day. Heavyweights like Reliance Industries and State Bank of India put pressure on the indices, while buying in metal and IT stocks helped limit the losses.The Nifty closed 57.85 points, or 0.23 per cent, higher at 25,482.50. The Sensex ended up 50.15 points, or 0.06 per cent, at 82,276.07.Analysts said that the 25,400 level is acting as immediate structura…
Mumbai, Jan 28 (IANS) Indian equity benchmark indices Sensex and Nifty ended Wednesday’s session with modest gains, managing to stay in the green despite sharp volatility through the day. Investor sentiment was influenced by December-quarter earnings announcements and the finalisation of the India–European Union Free Trade Agreement.The Sensex closed at 82,345, rising 487 points, or 0.60 per cent. During the session, the index moved between a high of 82,504 and a low of 81,815 as markets swu…
New Delhi, Jan 26 (IANS) Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).In its Enforcement Report, the US health regulator said the US-based arm of Mumbai-headquartered Sun Pharma is recalling more than 26,000 bottles of a generic medicine used to treat dandruff and skin conditions that cause inflammation and itching.Sun…